Thumbnail Image
Publication

Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung cancer

Haslett, Kate
; ; 
Koh, P
; 
Ashcroft, Linda
; 
Asselin, M
; ; 
Harris, C
; 
Jackson, Alan
; 
Manoharan, Prakash
; 
Mullan, Damian
... show 3 more
Citations
Altmetric:
Abstract
Authors
Haslett, Kate
Blackhall, Fiona H
Koh, P
Ashcroft, Linda
Asselin, M
Dive, Caroline
Harris, C
Jackson, Alan
Manoharan, Prakash
Mullan, Damian
Ryder, W David J
Taylor, Benjamin
Faivre-Finn, Corinne
Affiliation
Oncology, The University of Manchester, and The Christie NHS Foundation Trust, Manchester
Description
Date
2018-01
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung cancer 2018, 115:S65 Lung Cancer
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620948
Embedded videos